Salvador Calleja-Alarcón

Salvador Calleja-Alarcón

Auto-generated profile, based on publicly available information

Salvador Calleja-Alarcón

Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Unidad de Cuidados Intensivos. Ciudad de México, México

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2021 in Cureus
Verified
Journal Article
Open access
PDF file
SWSalomon Waizel-Haiat
Salomon Waizel-Haiat
JGJose Alberto Guerrero-Paz
Jose Alberto Guerrero-Paz
LSLuis Alejandro Sánchez-Hurtado
Luis Alejandro Sánchez-Hurtado
SCSalvador Calleja-Alarcon
Salvador Calleja-Alarcon
LRLaura Romero-Gutierrez
Laura Romero-Gutierrez
Mucormycosis is an invasive fungal infection, often acute and extremely severe, occurring in patients with an underlying condition. Coinfection in patients with coronavirus disease 2019 (COVID-19) has been reported, often bacterial. A 24-year-old female is presented with acute fatal rhino-orbital mucormycosis and COVID-19. We report one of the first cases of rhino-orbital mucormycosis and COVID-19. With this case, we highlight the importance of considering mycotic coinfection in COVID-19 patients with diabetes.

9 November 2023 in Clinical and Translational Science
Verified
Journal Article
Open access
Ruth Madera-SandovalRuth Madera-Sandoval
Ruth Madera-Sandoval
ACArturo Cerbulo
Arturo Cerbulo
LALourdes Andrea Arriaga-Pizano
Lourdes Andrea Arriaga-Pizano
GCGraciela Libier Cabrera‐Rivera
Graciela Libier Cabrera‐Rivera
EBEdna Basilio‐Gálvez
Edna Basilio‐Gálvez
EFEduardo Ferat‐Osorio
Eduardo Ferat‐Osorio
The difficulty in predicting fatal outcomes in patients with coronavirus disease 2019 (COVID‐19) impacts the general morbidity and mortality due to severe acute respiratory syndrome‐coronavirus 2 infection, as it wears out the hospital services that care for these patients. Unfortunately, in several of the candidates for prognostic biomarkers proposed, the predictive power is compromised when patients have pre‐existing comorbidities. A cohort of 147 patients hospitalized for severe COVID‐19 was included in a descriptive, observational, single‐center, and prospective study. Patients were recruited during the first COVID‐19 pandemic wave (April–November 2020). Data were collected from the clinical history whereas immunophenotyping by multiparameter flow cytometry analysis allowed us to assess the expression of surface markers on peripheral leucocyte. Patients were grouped according to the outcome in survivors or non‐survivors. The prognostic value of leucocyte, cytokines or HLA‐DR, CD39, and CD73 was calculated. Hypertension and chronic renal failure but not obesity and diabetes were conditions more frequent among the deceased patient group. Mixed hypercytokinemia, including inflammatory (IL‐6) and anti‐inflammatory (IL‐10) cytokines, was more evident in deceased patients. In the deceased patient group, lymphopenia with a higher neutrophil‐lymphocyte ratio (NLR) value was present. HLA‐DR expression and the percentage of CD39+ cells were higher than non‐COVID‐19 patients but remained similar despite the outcome. Receiver operating characteristic analysis and cutoff value of NLR (69.6%, 9.4), percentage NLR (pNLR; 71.1%, 13.6), and IL‐6 (79.7%, 135.2 pg/mL). The expression of HLA‐DR, CD39, and CD73, as many serum cytokines (other than IL‐6) and chemokines levels do not show prognostic potential, were compared to NLR and pNLR values.

2 May 2022
Verified
Journal Article
Open access
SCSalvador Calleja-Alarcón
Salvador Calleja-Alarcón
LSLuis Alejandro Sánchez-Hurtado
Luis Alejandro Sánchez-Hurtado
LRLaura Romero-Gutiérrez
Laura Romero-Gutiérrez
JGJuan Carlos Guerrero-Escobar
Juan Carlos Guerrero-Escobar
JÁJuan Emmanuel Ávila-García
Juan Emmanuel Ávila-García
La ketamina es utilizada en anestesia intravenosa en el mantenimiento en la anestesia general. Su efecto cuenta con propiedades para prevenir la dificultad respiratoria asociada a broncoconstricción y la secreción de histamina asociada a crisis asmática. Estos efectos derivan de la acción directa en el músculo bronquial, así como de la potencialización de las catecolaminas, por lo que su uso muy controversial, ya que hasta el día de hoy no hay suficientes estudios que lo sustenten. Además, el efecto de la ketamina en el broncoespasmo debido a anafilaxia no está estudiado. El tratamiento de elección es la epinefrina y hay factores que están asociados en el éxito de esta. El objetivo fue presentar el caso de una paciente con antecedente de alergia a midazolam, que presentó broncoespasmo al estar en contacto con este y a la que se le administró tratamiento no convencional con resultados favorables. presentamos el caso de una mujer joven con antecedentes de alergias a medicamentos, específicamente a benzodiacepinas, la cual presentó broncoespasmo y caída de la saturación posteriores al contacto con midazolam intraocular mientras laboraba. Se propuso la utilización de ketamina posterior a adrenalina, betaagonista y anticolinérgicos inhalados, esteroide y antihistamínico. es necesario hacer estudios que demuestren la eficacia de la ketamina en este contexto en particular; en este caso, los resultados fueron positivos.

3 November 2025
Verified
Journal Article
Open access
SCSalvador Calleja-Alarcón
Salvador Calleja-Alarcón
LSLuis Alejandro Sánchez-Hurtado
Luis Alejandro Sánchez-Hurtado
RRRodolfo Rivas-Ruiz
Rodolfo Rivas-Ruiz
LRLaura Romero-Gutiérrez
Laura Romero-Gutiérrez
In the article by Sánchez González, a detailed description of demographic and clinical variables is presented in a cohort of 224 patients. However, the lack of inferential statistical analysis limits the ability to establish robust associations. Based on previous evidence, we propose complementing the analysis using multiple logistic regression. When applying this model to the reported data, we found that male sex and exclusive insulin therapy were significantly associated with a higher risk of severe hypoglycemia.

3 March 2026
Verified
Journal Article
Open access
SCSalvador Calleja-Alarcón
Salvador Calleja-Alarcón
LSLuis Alejandro Sánchez-Hurtado
Luis Alejandro Sánchez-Hurtado
LRLaura Romero-Gutiérrez
Laura Romero-Gutiérrez
SDSudán Jareth Diaz-Reyna
Sudán Jareth Diaz-Reyna
MAMarco Antonio Amador-González
Marco Antonio Amador-González
Approximately 30% of surgical procedures in the United States require orotracheal intubation. Generally laryngeal and tracheal injuries are rare. However, when they do occur, they can lead to major complications. Subcutaneous emphysema is the most common clinical presentation and is mostly treated conservatively and self-limiting. However, when it is Grade V, control strategies should be considered. There are reports in the literature on micro-drainage of subcutaneous emphysema through a fenestrated peripheral venous catheter with satisfactory results. We present the case of a 69-year-old diabetic man with hypertension and a history of pulmonary thromboembolism. He presented with a Grade II tracheal injury and Grade V subcutaneous emphysema. Micro-drainage of subcutaneous emphysema was performed through a size 14 peripheral venous catheter with fenestration, with adequate results. The peripheral venous catheter for microdrainage is a minimally invasive option for the treatment of grade V subcutaneous emphysema associated with tracheal injury. It can be a conservative strategy and, in some cases, can avoid the need for major interventions.

2 January 2023
Verified
Journal Article
Open access
ALAura Angélica López-García
Aura Angélica López-García
MRMiguel Ángel Ramos-Choreño
Miguel Ángel Ramos-Choreño
LSLuis Alejandro Sánchez-Hurtado
Luis Alejandro Sánchez-Hurtado
LRLaura Romero-Gutiérrez
Laura Romero-Gutiérrez
SCSalvador Calleja-Alarcón
Salvador Calleja-Alarcón
TCTania Colín-Martínez
Tania Colín-Martínez
The COVID-19 disease has represented one of the most important threats to health. The most severe form is acute respiratory distress syndrome (ARDS). The inflammatory response can cause hematologic changes. To determine the association between the Neutrophil/lymphocyte ratio (NLR) and the mean platelet volume (MPV) associated with mortality in critically ill patients with COVID-19 and ARDS. A retrospective study was carried out in an intensive care unit (ICU) in a public hospital, with patients in critical condition due to COVID-19 and on mechanical ventilation. The clinical characteristics of admission and severity of the disease were recorded. The end point was the ICU discharge condition. 162 subjects were gathered, 103 were men, with a mean age of 54.54 ± 13.53 years. 66.7% died in the ICU. The NLR had an area under the curve (aROC) of 0.62, with a cut-off point for mortality of > 7.04, sensitivity of 94.4%, specificity of 29.63%. The VPM had an aROC of 0.65 with a cut-off point > 9.5, sensitivity of 30.84%, and specificity of 92.59%; finally, the APACHE II had an aROC of 0.67 with a cut-off point > 14, sensitivity of 51.4% and specificity of 80%. The NLR presented an odds ratio (OR) of 5.02, the VPM 2.06 and the APACHE II score 1.16. NLR, MPV, and APACHE II at ICU admission are associated with mortality for critically ill patients with COVID-19.